Status:
COMPLETED
Study of Specimens From Young Patients With Neuroblastoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Localized Resectable Neuroblastoma
Localized Unresectable Neuroblastoma
Eligibility:
All Genders
Up to 18 years
Brief Summary
This research trial studies specimens from young patients with neuroblastoma. Studying the genes expressed in specimens from patients with cancer may help doctors identify biomarkers related to cancer...
Detailed Description
PRIMARY OBJECTIVES: I. Establish a robust messenger ribonucleic acid (mRNA) gene expression classifier for improved outcome prediction in children with neuroblastoma by using real-time polymerase cha...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of primary Neuroblastoma
- Untreated disease
- RNA samples from primary untreated NB-tumors available in Children's Oncology Group (COG) repository
- At least 60% tumor cells
- At least 2 years of follow-up from the date of diagnosis
- Full clinical and biological annotation
Exclusion
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00958659
Start Date
December 1 2008
End Date
May 1 2016
Last Update
May 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Philadelphia, Pennsylvania, United States, 19104